Accueil   Diary - News   All news ImmunID at ASCO Annual Meeting

ImmunID at ASCO Annual Meeting

ImmunID, the immune companion diagnostics for precision medicine company, today announces that a collaborative work on prediction of response to the antiPD1 and anti-CTLA-4 immune checkpoint inhibitors in melanoma using ImmunTraCkeR® has been selected for a poster presentation during the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, IL on June 3-7, 2016. These results were generated in collaboration with Zurich University Hospital (Switzerland) and the NKI (The Netherlands), two leading European clinical centers in Immuno-Oncology.

Read the press release